Top Clinical Trials companies in South Korea by Current Liabilities
South Korea
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.90 B
|
Dec. 31, 2023 | USD 119.86 | -2.20% |
|
South Korea |
|
| 2 |
USD 185.56 M
|
Dec. 31, 2023 | USD 70.28 | -5.55% |
|
South Korea |
|
| 3 |
USD 111.01 M
|
Dec. 31, 2023 | USD 11.62 | -0.90% |
|
South Korea |
|
| 4 |
USD 77.12 M
|
Dec. 31, 2023 | USD 240.05 | -5.25% |
|
South Korea |
|
| 5 |
USD 64.32 M
|
Dec. 31, 2023 | USD 54.68 | -7.62% |
|
South Korea |
|
| 6 |
USD 42.66 M
|
Dec. 31, 2023 | USD 1.61 | -1.19% |
|
South Korea |
|
| 7 |
USD 41.88 M
|
Dec. 31, 2023 | USD 3.04 | -3.81% |
|
South Korea |
|
| 8 |
USD 32.07 M
|
Dec. 31, 2023 | USD 25.27 | 1.91% |
|
South Korea |
|
| 9 |
USD 26.76 M
|
Dec. 31, 2023 | USD 17.88 | -1.83% |
|
South Korea |
|
| 10 |
USD 20.94 M
|
Dec. 31, 2023 | USD 11.00 | -3.03% |
|
South Korea |
|
| 11 |
USD 17.56 M
|
Dec. 31, 2023 | USD 1.42 | -2.25% |
|
South Korea |
|
| 12 |
USD 12.03 M
|
Dec. 31, 2023 | USD 1.23 | -3.88% |
|
South Korea |
|
| 13 |
USD 10.87 M
|
Dec. 31, 2023 | USD 1.01 | -3.22% |
|
South Korea |
|
| 14 |
USD 8.26 M
|
Dec. 31, 2023 | USD 11.83 | -21.52% |
|
South Korea |
|
| 15 |
USD 5.95 M
|
Dec. 31, 2023 | USD 2.33 | -4.21% |
|
South Korea |
|
| 16 |
USD 5.29 M
|
Dec. 31, 2023 | USD 64.97 | -2.50% |
|
South Korea |
|
| 17 |
USD 5.04 M
|
Dec. 31, 2023 | USD 10.77 | -3.15% |
|
South Korea |
Frequently Asked Questions
-
Which Clinical Trials company in South Korea has the highest Current Liabilities ?
The Clinical Trials company in South Korea with the highest Current Liabilities is Celltrion, Inc. (KSE: 068270.KS) at USD 1.90 B.
-
Which Clinical Trials company in South Korea has the lowest Current Liabilities ?
The Clinical Trials company in South Korea with the lowest Current Liabilities is OliX Pharmaceuticals,Inc (KOSDAQ: 226950.KQ) at USD 5.04 M.
-
What are the top 10 Clinical Trials companies in South Korea by Current Liabilities ?
The top 10 Clinical Trials companies in South Korea by Current Liabilities are Celltrion, Inc., SK Biopharmaceuticals Co., Ltd., Samjin Pharmaceuticals Co., Ltd., ALTEOGEN Inc., ST Pharm Co.,Ltd., CrystalGenomics, Inc., Genexine, Inc., ABL Bio Inc., Oscotec Inc. and Boditech Med Inc..
-
What are the bottom 10 Clinical Trials companies in South Korea by Current Liabilities ?
The bottom 10 Clinical Trials companies in South Korea by Current Liabilities are OliX Pharmaceuticals,Inc, Peptron, Inc., MedPacto, Inc., Anterogen.Co.,Ltd., Enzychem Lifesciences Corporation, Gencurix Inc., GeneOne Life Science, Inc., Boditech Med Inc., Oscotec Inc. and ABL Bio Inc..
